The use of Stem Cells for COVID-19 Therapy

There are now numerous uses and investigations for experimental stem cell therapy in severely ill COVID-19 patients, particularly MSC therapy. MSCs are produced from the mesoderm and ectoderm during the early stages of embryonic development, and they have gotten a lot of press because of their multidirectional differentiation capability, immunomodulatory capabilities, and lack of ethical issues. stem cell treatment offers extensive clinical application possibilities and far-reaching relevance thanks to the ongoing exploration of stem cell clinical research and data mining.

    Related Conference of The use of Stem Cells for COVID-19 Therapy

    December 09-10, 2024

    17th World Congress on Stem Cell Research

    Dubai, UAE
    December 12-13, 2024

    17th International Conference on Human Genomics and Genomic Medicine

    Dubai, UAE
    December 12-13, 2024

    8th Annual Congress on Soil, Plant and Water Sciences

    Dubai, UAE
    February 24-25, 2025

    19th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    April 03-04, 2025

    15th International Conference on Human Genetics and Genetic Diseases

    Madrid, Spain
    April 03-04, 2025

    18th International Conference on Genomics & Pharmacogenomics

    Madrid, Spain
    April 14-15, 2025

    8th Annual Conference on Stem Cell and Regenerative Medicine

    Budapest, Hungary
    April 29-30, 2025

    3rd International Conference on Cell Science and Molecular Biology

    Barcelona, Spain
    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 12-13, 2025

    13th World Congress on Human Genetics and Genetic Diseases

    London, UK
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany

    The use of Stem Cells for COVID-19 Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in